Therapeutic responses, prognostic factor and therapeutic strategy evaluation for canine lymphoma
博士 === 國立臺灣大學 === 獸醫學研究所 === 104 === Lymphoma is one of the common neoplasms in dogs. CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) is the most used chemotherapy for treating canine lymphoma. In order to provide better therapeutic quality and longer survival time in lymphoma pa...
Main Authors: | Shang-Lin Wang, 王尚麟 |
---|---|
Other Authors: | 廖泰慶 |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/98191847741788948797 |
Similar Items
-
Identification of Phenotype and Evaluation of Therapeutic Drugs on Canine Lymphoma Cells
by: Rui-Hong Wu, et al.
Published: (2014) -
Canine Cancer: Strategies in Experimental Therapeutics
by: Douglas H. Thamm, et al.
Published: (2019-11-01) -
Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma
by: Diana Sánchez, et al.
Published: (2015-12-01) -
Targeting Copper: A Therapeutic Strategy In Lymphoma
by: Lee, Kristy
Published: (2013) -
Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications
by: Can Küçük, et al.
Published: (2020-02-01)